Advertisement

Index by author

April 01, 2017; Volume 91,Issue 4

A

  1. Alfonzo-Méndez, Marco A.

    1. Protein Kinase C Activation Promotes α1B-Adrenoceptor Internalization and Late Endosome Trafficking through Rab9 Interaction. Role in Heterologous Desensitization
      Marco A. Alfonzo-Méndez, David A. Hernández-Espinosa, Gabriel Carmona-Rosas, M. Teresa Romero-Ávila, Guadalupe Reyes-Cruz and J. Adolfo García-Sáinz
      Molecular Pharmacology April 2017, 91 (4) 296-306; DOI: https://doi.org/10.1124/mol.116.106583

  2. Anderson, Karen S.

    1. Structural and Preclinical Studies of Computationally Designed Non-Nucleoside Reverse Transcriptase Inhibitors for Treating HIV infection
      Shalley N. Kudalkar, Jagadish Beloor, Albert H. Chan, Won-Gil Lee, William L. Jorgensen, Priti Kumar and Karen S. Anderson
      Molecular Pharmacology April 2017, 91 (4) 383-391; DOI: https://doi.org/10.1124/mol.116.107755

B

  1. Baek, Suk-Hwan

    1. Trim13 Potentiates Toll-Like Receptor 2–Mediated Nuclear Factor κB Activation via K29-Linked Polyubiquitination of Tumor Necrosis Factor Receptor-Associated Factor 6
      Bin Huang and Suk-Hwan Baek
      Molecular Pharmacology April 2017, 91 (4) 307-316; DOI: https://doi.org/10.1124/mol.116.106716

  2. Bean, Bruce P.

    1. Lacosamide Inhibition of Nav1.7 Voltage-Gated Sodium Channels: Slow Binding to Fast-Inactivated States
      Sooyeon Jo and Bruce P. Bean
      Molecular Pharmacology April 2017, 91 (4) 277-286; DOI: https://doi.org/10.1124/mol.116.106401

  3. Bell, Sydney

    1. AKT1, LKB1, and YAP1 Revealed as MYC Interactors with NanoLuc-Based Protein-Fragment Complementation Assay
      Xiulei Mo, Qi Qi, Andrei A. Ivanov, Qiankun Niu, Yin Luo, Jonathan Havel, Russell Goetze, Sydney Bell, Carlos S. Moreno, Lee A.D. Cooper, Margaret A. Johns, Fadlo R. Khuri, Yuhong Du and Haian Fu
      Molecular Pharmacology April 2017, 91 (4) 339-347; DOI: https://doi.org/10.1124/mol.116.107623

  4. Beloor, Jagadish

    1. Structural and Preclinical Studies of Computationally Designed Non-Nucleoside Reverse Transcriptase Inhibitors for Treating HIV infection
      Shalley N. Kudalkar, Jagadish Beloor, Albert H. Chan, Won-Gil Lee, William L. Jorgensen, Priti Kumar and Karen S. Anderson
      Molecular Pharmacology April 2017, 91 (4) 383-391; DOI: https://doi.org/10.1124/mol.116.107755

  5. Bennett, Phillip R.

    1. Open Access
      Differential Effects of Oxytocin Receptor Antagonists, Atosiban and Nolasiban, on Oxytocin Receptor–Mediated Signaling in Human Amnion and Myometrium
      Sung Hye Kim, Oliver Pohl, Andre Chollet, Jean-Pierre Gotteland, Adam D. J. Fairhurst, Phillip R. Bennett and Vasso Terzidou
      Molecular Pharmacology April 2017, 91 (4) 403-415; DOI: https://doi.org/10.1124/mol.116.106013

  6. Bock, Andreas

    1. A New Molecular Mechanism To Engineer Protean Agonism at a G Protein–Coupled Receptor
      Anna De Min, Carlo Matera, Andreas Bock, Janine Holze, Jessica Kloeckner, Mathias Muth, Christian Traenkle, Marco De Amici, Terry Kenakin, Ulrike Holzgrabe, Clelia Dallanoce, Evi Kostenis, Klaus Mohr and Ramona Schrage
      Molecular Pharmacology April 2017, 91 (4) 348-356; DOI: https://doi.org/10.1124/mol.116.107276

  7. Bouvier, Michel

    1. Targeting a Proteinase-Activated Receptor 4 (PAR4) Carboxyl Terminal Motif to Regulate Platelet Function
      Rithwik Ramachandran, Koichiro Mihara, Pierre Thibeault, Christina M. Vanderboor, Björn Petri, Mahmoud Saifeddine, Michel Bouvier and Morley D. Hollenberg
      Molecular Pharmacology April 2017, 91 (4) 287-295; DOI: https://doi.org/10.1124/mol.116.106526

  8. Burger, Pieter B.

    1. Functional Evaluation of a De Novo GRIN2A Mutation Identified in a Patient with Profound Global Developmental Delay and Refractory Epilepsy
      Wenjuan Chen, Anel Tankovic, Pieter B. Burger, Hirofumi Kusumoto, Stephen F. Traynelis and Hongjie Yuan
      Molecular Pharmacology April 2017, 91 (4) 317-330; DOI: https://doi.org/10.1124/mol.116.106781

C

  1. Cannon, Ronald E.

    1. Ceramide 1-Phosphate Increases P-Glycoprotein Transport Activity at the Blood-Brain Barrier via Prostaglandin E2 Signaling
      Emily V. Mesev, David S. Miller and Ronald E. Cannon
      Molecular Pharmacology April 2017, 91 (4) 373-382; DOI: https://doi.org/10.1124/mol.116.107169

  2. Carmona-Rosas, Gabriel

    1. Protein Kinase C Activation Promotes α1B-Adrenoceptor Internalization and Late Endosome Trafficking through Rab9 Interaction. Role in Heterologous Desensitization
      Marco A. Alfonzo-Méndez, David A. Hernández-Espinosa, Gabriel Carmona-Rosas, M. Teresa Romero-Ávila, Guadalupe Reyes-Cruz and J. Adolfo García-Sáinz
      Molecular Pharmacology April 2017, 91 (4) 296-306; DOI: https://doi.org/10.1124/mol.116.106583

  3. Chan, Albert H.

    1. Structural and Preclinical Studies of Computationally Designed Non-Nucleoside Reverse Transcriptase Inhibitors for Treating HIV infection
      Shalley N. Kudalkar, Jagadish Beloor, Albert H. Chan, Won-Gil Lee, William L. Jorgensen, Priti Kumar and Karen S. Anderson
      Molecular Pharmacology April 2017, 91 (4) 383-391; DOI: https://doi.org/10.1124/mol.116.107755

  4. Chen, Wenjuan

    1. Functional Evaluation of a De Novo GRIN2A Mutation Identified in a Patient with Profound Global Developmental Delay and Refractory Epilepsy
      Wenjuan Chen, Anel Tankovic, Pieter B. Burger, Hirofumi Kusumoto, Stephen F. Traynelis and Hongjie Yuan
      Molecular Pharmacology April 2017, 91 (4) 317-330; DOI: https://doi.org/10.1124/mol.116.106781

  5. Chollet, Andre

    1. Open Access
      Differential Effects of Oxytocin Receptor Antagonists, Atosiban and Nolasiban, on Oxytocin Receptor–Mediated Signaling in Human Amnion and Myometrium
      Sung Hye Kim, Oliver Pohl, Andre Chollet, Jean-Pierre Gotteland, Adam D. J. Fairhurst, Phillip R. Bennett and Vasso Terzidou
      Molecular Pharmacology April 2017, 91 (4) 403-415; DOI: https://doi.org/10.1124/mol.116.106013

  6. Cooper, Lee A.D.

    1. AKT1, LKB1, and YAP1 Revealed as MYC Interactors with NanoLuc-Based Protein-Fragment Complementation Assay
      Xiulei Mo, Qi Qi, Andrei A. Ivanov, Qiankun Niu, Yin Luo, Jonathan Havel, Russell Goetze, Sydney Bell, Carlos S. Moreno, Lee A.D. Cooper, Margaret A. Johns, Fadlo R. Khuri, Yuhong Du and Haian Fu
      Molecular Pharmacology April 2017, 91 (4) 339-347; DOI: https://doi.org/10.1124/mol.116.107623

D

  1. Dallanoce, Clelia

    1. A New Molecular Mechanism To Engineer Protean Agonism at a G Protein–Coupled Receptor
      Anna De Min, Carlo Matera, Andreas Bock, Janine Holze, Jessica Kloeckner, Mathias Muth, Christian Traenkle, Marco De Amici, Terry Kenakin, Ulrike Holzgrabe, Clelia Dallanoce, Evi Kostenis, Klaus Mohr and Ramona Schrage
      Molecular Pharmacology April 2017, 91 (4) 348-356; DOI: https://doi.org/10.1124/mol.116.107276

  2. De Amici, Marco

    1. A New Molecular Mechanism To Engineer Protean Agonism at a G Protein–Coupled Receptor
      Anna De Min, Carlo Matera, Andreas Bock, Janine Holze, Jessica Kloeckner, Mathias Muth, Christian Traenkle, Marco De Amici, Terry Kenakin, Ulrike Holzgrabe, Clelia Dallanoce, Evi Kostenis, Klaus Mohr and Ramona Schrage
      Molecular Pharmacology April 2017, 91 (4) 348-356; DOI: https://doi.org/10.1124/mol.116.107276

  3. De Min, Anna

    1. A New Molecular Mechanism To Engineer Protean Agonism at a G Protein–Coupled Receptor
      Anna De Min, Carlo Matera, Andreas Bock, Janine Holze, Jessica Kloeckner, Mathias Muth, Christian Traenkle, Marco De Amici, Terry Kenakin, Ulrike Holzgrabe, Clelia Dallanoce, Evi Kostenis, Klaus Mohr and Ramona Schrage
      Molecular Pharmacology April 2017, 91 (4) 348-356; DOI: https://doi.org/10.1124/mol.116.107276

  4. Du, Yuhong

    1. AKT1, LKB1, and YAP1 Revealed as MYC Interactors with NanoLuc-Based Protein-Fragment Complementation Assay
      Xiulei Mo, Qi Qi, Andrei A. Ivanov, Qiankun Niu, Yin Luo, Jonathan Havel, Russell Goetze, Sydney Bell, Carlos S. Moreno, Lee A.D. Cooper, Margaret A. Johns, Fadlo R. Khuri, Yuhong Du and Haian Fu
      Molecular Pharmacology April 2017, 91 (4) 339-347; DOI: https://doi.org/10.1124/mol.116.107623

F

  1. Fairhurst, Adam D. J.

    1. Open Access
      Differential Effects of Oxytocin Receptor Antagonists, Atosiban and Nolasiban, on Oxytocin Receptor–Mediated Signaling in Human Amnion and Myometrium
      Sung Hye Kim, Oliver Pohl, Andre Chollet, Jean-Pierre Gotteland, Adam D. J. Fairhurst, Phillip R. Bennett and Vasso Terzidou
      Molecular Pharmacology April 2017, 91 (4) 403-415; DOI: https://doi.org/10.1124/mol.116.106013

  2. Fu, Haian

    1. AKT1, LKB1, and YAP1 Revealed as MYC Interactors with NanoLuc-Based Protein-Fragment Complementation Assay
      Xiulei Mo, Qi Qi, Andrei A. Ivanov, Qiankun Niu, Yin Luo, Jonathan Havel, Russell Goetze, Sydney Bell, Carlos S. Moreno, Lee A.D. Cooper, Margaret A. Johns, Fadlo R. Khuri, Yuhong Du and Haian Fu
      Molecular Pharmacology April 2017, 91 (4) 339-347; DOI: https://doi.org/10.1124/mol.116.107623

G

  1. García-Sáinz, J. Adolfo

    1. Protein Kinase C Activation Promotes α1B-Adrenoceptor Internalization and Late Endosome Trafficking through Rab9 Interaction. Role in Heterologous Desensitization
      Marco A. Alfonzo-Méndez, David A. Hernández-Espinosa, Gabriel Carmona-Rosas, M. Teresa Romero-Ávila, Guadalupe Reyes-Cruz and J. Adolfo García-Sáinz
      Molecular Pharmacology April 2017, 91 (4) 296-306; DOI: https://doi.org/10.1124/mol.116.106583

  2. Goetze, Russell

    1. AKT1, LKB1, and YAP1 Revealed as MYC Interactors with NanoLuc-Based Protein-Fragment Complementation Assay
      Xiulei Mo, Qi Qi, Andrei A. Ivanov, Qiankun Niu, Yin Luo, Jonathan Havel, Russell Goetze, Sydney Bell, Carlos S. Moreno, Lee A.D. Cooper, Margaret A. Johns, Fadlo R. Khuri, Yuhong Du and Haian Fu
      Molecular Pharmacology April 2017, 91 (4) 339-347; DOI: https://doi.org/10.1124/mol.116.107623

  3. Gotteland, Jean-Pierre

    1. Open Access
      Differential Effects of Oxytocin Receptor Antagonists, Atosiban and Nolasiban, on Oxytocin Receptor–Mediated Signaling in Human Amnion and Myometrium
      Sung Hye Kim, Oliver Pohl, Andre Chollet, Jean-Pierre Gotteland, Adam D. J. Fairhurst, Phillip R. Bennett and Vasso Terzidou
      Molecular Pharmacology April 2017, 91 (4) 403-415; DOI: https://doi.org/10.1124/mol.116.106013

H

  1. Havel, Jonathan

    1. AKT1, LKB1, and YAP1 Revealed as MYC Interactors with NanoLuc-Based Protein-Fragment Complementation Assay
      Xiulei Mo, Qi Qi, Andrei A. Ivanov, Qiankun Niu, Yin Luo, Jonathan Havel, Russell Goetze, Sydney Bell, Carlos S. Moreno, Lee A.D. Cooper, Margaret A. Johns, Fadlo R. Khuri, Yuhong Du and Haian Fu
      Molecular Pharmacology April 2017, 91 (4) 339-347; DOI: https://doi.org/10.1124/mol.116.107623

  2. Hernández-Espinosa, David A.

    1. Protein Kinase C Activation Promotes α1B-Adrenoceptor Internalization and Late Endosome Trafficking through Rab9 Interaction. Role in Heterologous Desensitization
      Marco A. Alfonzo-Méndez, David A. Hernández-Espinosa, Gabriel Carmona-Rosas, M. Teresa Romero-Ávila, Guadalupe Reyes-Cruz and J. Adolfo García-Sáinz
      Molecular Pharmacology April 2017, 91 (4) 296-306; DOI: https://doi.org/10.1124/mol.116.106583

  3. Hollenberg, Morley D.

    1. Targeting a Proteinase-Activated Receptor 4 (PAR4) Carboxyl Terminal Motif to Regulate Platelet Function
      Rithwik Ramachandran, Koichiro Mihara, Pierre Thibeault, Christina M. Vanderboor, Björn Petri, Mahmoud Saifeddine, Michel Bouvier and Morley D. Hollenberg
      Molecular Pharmacology April 2017, 91 (4) 287-295; DOI: https://doi.org/10.1124/mol.116.106526

  4. Holze, Janine

    1. A New Molecular Mechanism To Engineer Protean Agonism at a G Protein–Coupled Receptor
      Anna De Min, Carlo Matera, Andreas Bock, Janine Holze, Jessica Kloeckner, Mathias Muth, Christian Traenkle, Marco De Amici, Terry Kenakin, Ulrike Holzgrabe, Clelia Dallanoce, Evi Kostenis, Klaus Mohr and Ramona Schrage
      Molecular Pharmacology April 2017, 91 (4) 348-356; DOI: https://doi.org/10.1124/mol.116.107276

  5. Holzgrabe, Ulrike

    1. A New Molecular Mechanism To Engineer Protean Agonism at a G Protein–Coupled Receptor
      Anna De Min, Carlo Matera, Andreas Bock, Janine Holze, Jessica Kloeckner, Mathias Muth, Christian Traenkle, Marco De Amici, Terry Kenakin, Ulrike Holzgrabe, Clelia Dallanoce, Evi Kostenis, Klaus Mohr and Ramona Schrage
      Molecular Pharmacology April 2017, 91 (4) 348-356; DOI: https://doi.org/10.1124/mol.116.107276

  6. Huang, Bin

    1. Trim13 Potentiates Toll-Like Receptor 2–Mediated Nuclear Factor κB Activation via K29-Linked Polyubiquitination of Tumor Necrosis Factor Receptor-Associated Factor 6
      Bin Huang and Suk-Hwan Baek
      Molecular Pharmacology April 2017, 91 (4) 307-316; DOI: https://doi.org/10.1124/mol.116.106716

I

  1. Ivanov, Andrei A.

    1. AKT1, LKB1, and YAP1 Revealed as MYC Interactors with NanoLuc-Based Protein-Fragment Complementation Assay
      Xiulei Mo, Qi Qi, Andrei A. Ivanov, Qiankun Niu, Yin Luo, Jonathan Havel, Russell Goetze, Sydney Bell, Carlos S. Moreno, Lee A.D. Cooper, Margaret A. Johns, Fadlo R. Khuri, Yuhong Du and Haian Fu
      Molecular Pharmacology April 2017, 91 (4) 339-347; DOI: https://doi.org/10.1124/mol.116.107623

J

  1. Jakobs, Barbara D.

    1. Modulation of Chemokine Receptor Function by Cholesterol: New Prospects for Pharmacological Intervention
      Daniel F. Legler, Christoph Matti, Julia M. Laufer, Barbara D. Jakobs, Vladimir Purvanov, Edith Uetz-von Allmen and Marcus Thelen
      Molecular Pharmacology April 2017, 91 (4) 331-338; DOI: https://doi.org/10.1124/mol.116.107151

  2. Jenkins, David Paul

    1. Structural Insights into the Atomistic Mechanisms of Action of Small Molecule Inhibitors Targeting the KCa3.1 Channel Pore
      Hai M. Nguyen, Vikrant Singh, Brandon Pressly, David Paul Jenkins, Heike Wulff and Vladimir Yarov-Yarovoy
      Molecular Pharmacology April 2017, 91 (4) 392-402; DOI: https://doi.org/10.1124/mol.116.108068

  3. Jo, Sooyeon

    1. Lacosamide Inhibition of Nav1.7 Voltage-Gated Sodium Channels: Slow Binding to Fast-Inactivated States
      Sooyeon Jo and Bruce P. Bean
      Molecular Pharmacology April 2017, 91 (4) 277-286; DOI: https://doi.org/10.1124/mol.116.106401

  4. Johns, Margaret A.

    1. AKT1, LKB1, and YAP1 Revealed as MYC Interactors with NanoLuc-Based Protein-Fragment Complementation Assay
      Xiulei Mo, Qi Qi, Andrei A. Ivanov, Qiankun Niu, Yin Luo, Jonathan Havel, Russell Goetze, Sydney Bell, Carlos S. Moreno, Lee A.D. Cooper, Margaret A. Johns, Fadlo R. Khuri, Yuhong Du and Haian Fu
      Molecular Pharmacology April 2017, 91 (4) 339-347; DOI: https://doi.org/10.1124/mol.116.107623

  5. Jorgensen, William L.

    1. Structural and Preclinical Studies of Computationally Designed Non-Nucleoside Reverse Transcriptase Inhibitors for Treating HIV infection
      Shalley N. Kudalkar, Jagadish Beloor, Albert H. Chan, Won-Gil Lee, William L. Jorgensen, Priti Kumar and Karen S. Anderson
      Molecular Pharmacology April 2017, 91 (4) 383-391; DOI: https://doi.org/10.1124/mol.116.107755

K

  1. Kenakin, Terry

    1. A New Molecular Mechanism To Engineer Protean Agonism at a G Protein–Coupled Receptor
      Anna De Min, Carlo Matera, Andreas Bock, Janine Holze, Jessica Kloeckner, Mathias Muth, Christian Traenkle, Marco De Amici, Terry Kenakin, Ulrike Holzgrabe, Clelia Dallanoce, Evi Kostenis, Klaus Mohr and Ramona Schrage
      Molecular Pharmacology April 2017, 91 (4) 348-356; DOI: https://doi.org/10.1124/mol.116.107276

  2. Khuri, Fadlo R.

    1. AKT1, LKB1, and YAP1 Revealed as MYC Interactors with NanoLuc-Based Protein-Fragment Complementation Assay
      Xiulei Mo, Qi Qi, Andrei A. Ivanov, Qiankun Niu, Yin Luo, Jonathan Havel, Russell Goetze, Sydney Bell, Carlos S. Moreno, Lee A.D. Cooper, Margaret A. Johns, Fadlo R. Khuri, Yuhong Du and Haian Fu
      Molecular Pharmacology April 2017, 91 (4) 339-347; DOI: https://doi.org/10.1124/mol.116.107623

  3. Kim, Sung Hye

    1. Open Access
      Differential Effects of Oxytocin Receptor Antagonists, Atosiban and Nolasiban, on Oxytocin Receptor–Mediated Signaling in Human Amnion and Myometrium
      Sung Hye Kim, Oliver Pohl, Andre Chollet, Jean-Pierre Gotteland, Adam D. J. Fairhurst, Phillip R. Bennett and Vasso Terzidou
      Molecular Pharmacology April 2017, 91 (4) 403-415; DOI: https://doi.org/10.1124/mol.116.106013

  4. Kloeckner, Jessica

    1. A New Molecular Mechanism To Engineer Protean Agonism at a G Protein–Coupled Receptor
      Anna De Min, Carlo Matera, Andreas Bock, Janine Holze, Jessica Kloeckner, Mathias Muth, Christian Traenkle, Marco De Amici, Terry Kenakin, Ulrike Holzgrabe, Clelia Dallanoce, Evi Kostenis, Klaus Mohr and Ramona Schrage
      Molecular Pharmacology April 2017, 91 (4) 348-356; DOI: https://doi.org/10.1124/mol.116.107276

  5. Kostenis, Evi

    1. A New Molecular Mechanism To Engineer Protean Agonism at a G Protein–Coupled Receptor
      Anna De Min, Carlo Matera, Andreas Bock, Janine Holze, Jessica Kloeckner, Mathias Muth, Christian Traenkle, Marco De Amici, Terry Kenakin, Ulrike Holzgrabe, Clelia Dallanoce, Evi Kostenis, Klaus Mohr and Ramona Schrage
      Molecular Pharmacology April 2017, 91 (4) 348-356; DOI: https://doi.org/10.1124/mol.116.107276

  6. Kudalkar, Shalley N.

    1. Structural and Preclinical Studies of Computationally Designed Non-Nucleoside Reverse Transcriptase Inhibitors for Treating HIV infection
      Shalley N. Kudalkar, Jagadish Beloor, Albert H. Chan, Won-Gil Lee, William L. Jorgensen, Priti Kumar and Karen S. Anderson
      Molecular Pharmacology April 2017, 91 (4) 383-391; DOI: https://doi.org/10.1124/mol.116.107755

  7. Kumar, Priti

    1. Structural and Preclinical Studies of Computationally Designed Non-Nucleoside Reverse Transcriptase Inhibitors for Treating HIV infection
      Shalley N. Kudalkar, Jagadish Beloor, Albert H. Chan, Won-Gil Lee, William L. Jorgensen, Priti Kumar and Karen S. Anderson
      Molecular Pharmacology April 2017, 91 (4) 383-391; DOI: https://doi.org/10.1124/mol.116.107755

  8. Kusumoto, Hirofumi

    1. Functional Evaluation of a De Novo GRIN2A Mutation Identified in a Patient with Profound Global Developmental Delay and Refractory Epilepsy
      Wenjuan Chen, Anel Tankovic, Pieter B. Burger, Hirofumi Kusumoto, Stephen F. Traynelis and Hongjie Yuan
      Molecular Pharmacology April 2017, 91 (4) 317-330; DOI: https://doi.org/10.1124/mol.116.106781

L

  1. Laufer, Julia M.

    1. Modulation of Chemokine Receptor Function by Cholesterol: New Prospects for Pharmacological Intervention
      Daniel F. Legler, Christoph Matti, Julia M. Laufer, Barbara D. Jakobs, Vladimir Purvanov, Edith Uetz-von Allmen and Marcus Thelen
      Molecular Pharmacology April 2017, 91 (4) 331-338; DOI: https://doi.org/10.1124/mol.116.107151

  2. Law, Ping-Yee

    1. Epigenetic Activation of μ-Opioid Receptor Gene via Increased Expression and Function of Mitogen- and Stress-Activated Protein Kinase 1
      Yadav Wagley, Ping-Yee Law, Li-Na Wei and Horace H. Loh
      Molecular Pharmacology April 2017, 91 (4) 357-372; DOI: https://doi.org/10.1124/mol.116.106567

  3. Lee, Won-Gil

    1. Structural and Preclinical Studies of Computationally Designed Non-Nucleoside Reverse Transcriptase Inhibitors for Treating HIV infection
      Shalley N. Kudalkar, Jagadish Beloor, Albert H. Chan, Won-Gil Lee, William L. Jorgensen, Priti Kumar and Karen S. Anderson
      Molecular Pharmacology April 2017, 91 (4) 383-391; DOI: https://doi.org/10.1124/mol.116.107755

  4. Legler, Daniel F.

    1. Modulation of Chemokine Receptor Function by Cholesterol: New Prospects for Pharmacological Intervention
      Daniel F. Legler, Christoph Matti, Julia M. Laufer, Barbara D. Jakobs, Vladimir Purvanov, Edith Uetz-von Allmen and Marcus Thelen
      Molecular Pharmacology April 2017, 91 (4) 331-338; DOI: https://doi.org/10.1124/mol.116.107151

  5. Li, Ni

    1. Identification of a Novel Liver X Receptor Agonist that Regulates the Expression of Key Cholesterol Homeostasis Genes with Distinct Pharmacological Characteristics
      Ni Li, Xiao Wang, Yanni Xu, Yuan Lin, Ningyu Zhu, Peng Liu, Duo Lu and Shuyi Si
      Molecular Pharmacology April 2017, 91 (4) 264-276; DOI: https://doi.org/10.1124/mol.116.105213

  6. Lin, Yuan

    1. Identification of a Novel Liver X Receptor Agonist that Regulates the Expression of Key Cholesterol Homeostasis Genes with Distinct Pharmacological Characteristics
      Ni Li, Xiao Wang, Yanni Xu, Yuan Lin, Ningyu Zhu, Peng Liu, Duo Lu and Shuyi Si
      Molecular Pharmacology April 2017, 91 (4) 264-276; DOI: https://doi.org/10.1124/mol.116.105213

  7. Liu, Peng

    1. Identification of a Novel Liver X Receptor Agonist that Regulates the Expression of Key Cholesterol Homeostasis Genes with Distinct Pharmacological Characteristics
      Ni Li, Xiao Wang, Yanni Xu, Yuan Lin, Ningyu Zhu, Peng Liu, Duo Lu and Shuyi Si
      Molecular Pharmacology April 2017, 91 (4) 264-276; DOI: https://doi.org/10.1124/mol.116.105213

  8. Loh, Horace H.

    1. Epigenetic Activation of μ-Opioid Receptor Gene via Increased Expression and Function of Mitogen- and Stress-Activated Protein Kinase 1
      Yadav Wagley, Ping-Yee Law, Li-Na Wei and Horace H. Loh
      Molecular Pharmacology April 2017, 91 (4) 357-372; DOI: https://doi.org/10.1124/mol.116.106567

  9. Lu, Duo

    1. Identification of a Novel Liver X Receptor Agonist that Regulates the Expression of Key Cholesterol Homeostasis Genes with Distinct Pharmacological Characteristics
      Ni Li, Xiao Wang, Yanni Xu, Yuan Lin, Ningyu Zhu, Peng Liu, Duo Lu and Shuyi Si
      Molecular Pharmacology April 2017, 91 (4) 264-276; DOI: https://doi.org/10.1124/mol.116.105213

  10. Luo, Yin

    1. AKT1, LKB1, and YAP1 Revealed as MYC Interactors with NanoLuc-Based Protein-Fragment Complementation Assay
      Xiulei Mo, Qi Qi, Andrei A. Ivanov, Qiankun Niu, Yin Luo, Jonathan Havel, Russell Goetze, Sydney Bell, Carlos S. Moreno, Lee A.D. Cooper, Margaret A. Johns, Fadlo R. Khuri, Yuhong Du and Haian Fu
      Molecular Pharmacology April 2017, 91 (4) 339-347; DOI: https://doi.org/10.1124/mol.116.107623

M

  1. Matera, Carlo

    1. A New Molecular Mechanism To Engineer Protean Agonism at a G Protein–Coupled Receptor
      Anna De Min, Carlo Matera, Andreas Bock, Janine Holze, Jessica Kloeckner, Mathias Muth, Christian Traenkle, Marco De Amici, Terry Kenakin, Ulrike Holzgrabe, Clelia Dallanoce, Evi Kostenis, Klaus Mohr and Ramona Schrage
      Molecular Pharmacology April 2017, 91 (4) 348-356; DOI: https://doi.org/10.1124/mol.116.107276

  2. Matti, Christoph

    1. Modulation of Chemokine Receptor Function by Cholesterol: New Prospects for Pharmacological Intervention
      Daniel F. Legler, Christoph Matti, Julia M. Laufer, Barbara D. Jakobs, Vladimir Purvanov, Edith Uetz-von Allmen and Marcus Thelen
      Molecular Pharmacology April 2017, 91 (4) 331-338; DOI: https://doi.org/10.1124/mol.116.107151

  3. Mesev, Emily V.

    1. Ceramide 1-Phosphate Increases P-Glycoprotein Transport Activity at the Blood-Brain Barrier via Prostaglandin E2 Signaling
      Emily V. Mesev, David S. Miller and Ronald E. Cannon
      Molecular Pharmacology April 2017, 91 (4) 373-382; DOI: https://doi.org/10.1124/mol.116.107169

  4. Mihara, Koichiro

    1. Targeting a Proteinase-Activated Receptor 4 (PAR4) Carboxyl Terminal Motif to Regulate Platelet Function
      Rithwik Ramachandran, Koichiro Mihara, Pierre Thibeault, Christina M. Vanderboor, Björn Petri, Mahmoud Saifeddine, Michel Bouvier and Morley D. Hollenberg
      Molecular Pharmacology April 2017, 91 (4) 287-295; DOI: https://doi.org/10.1124/mol.116.106526

  5. Miller, David S.

    1. Ceramide 1-Phosphate Increases P-Glycoprotein Transport Activity at the Blood-Brain Barrier via Prostaglandin E2 Signaling
      Emily V. Mesev, David S. Miller and Ronald E. Cannon
      Molecular Pharmacology April 2017, 91 (4) 373-382; DOI: https://doi.org/10.1124/mol.116.107169

  6. Mo, Xiulei

    1. AKT1, LKB1, and YAP1 Revealed as MYC Interactors with NanoLuc-Based Protein-Fragment Complementation Assay
      Xiulei Mo, Qi Qi, Andrei A. Ivanov, Qiankun Niu, Yin Luo, Jonathan Havel, Russell Goetze, Sydney Bell, Carlos S. Moreno, Lee A.D. Cooper, Margaret A. Johns, Fadlo R. Khuri, Yuhong Du and Haian Fu
      Molecular Pharmacology April 2017, 91 (4) 339-347; DOI: https://doi.org/10.1124/mol.116.107623

  7. Mohr, Klaus

    1. A New Molecular Mechanism To Engineer Protean Agonism at a G Protein–Coupled Receptor
      Anna De Min, Carlo Matera, Andreas Bock, Janine Holze, Jessica Kloeckner, Mathias Muth, Christian Traenkle, Marco De Amici, Terry Kenakin, Ulrike Holzgrabe, Clelia Dallanoce, Evi Kostenis, Klaus Mohr and Ramona Schrage
      Molecular Pharmacology April 2017, 91 (4) 348-356; DOI: https://doi.org/10.1124/mol.116.107276

  8. Moreno, Carlos S.

    1. AKT1, LKB1, and YAP1 Revealed as MYC Interactors with NanoLuc-Based Protein-Fragment Complementation Assay
      Xiulei Mo, Qi Qi, Andrei A. Ivanov, Qiankun Niu, Yin Luo, Jonathan Havel, Russell Goetze, Sydney Bell, Carlos S. Moreno, Lee A.D. Cooper, Margaret A. Johns, Fadlo R. Khuri, Yuhong Du and Haian Fu
      Molecular Pharmacology April 2017, 91 (4) 339-347; DOI: https://doi.org/10.1124/mol.116.107623

  9. Muth, Mathias

    1. A New Molecular Mechanism To Engineer Protean Agonism at a G Protein–Coupled Receptor
      Anna De Min, Carlo Matera, Andreas Bock, Janine Holze, Jessica Kloeckner, Mathias Muth, Christian Traenkle, Marco De Amici, Terry Kenakin, Ulrike Holzgrabe, Clelia Dallanoce, Evi Kostenis, Klaus Mohr and Ramona Schrage
      Molecular Pharmacology April 2017, 91 (4) 348-356; DOI: https://doi.org/10.1124/mol.116.107276

N

  1. Nguyen, Hai M.

    1. Structural Insights into the Atomistic Mechanisms of Action of Small Molecule Inhibitors Targeting the KCa3.1 Channel Pore
      Hai M. Nguyen, Vikrant Singh, Brandon Pressly, David Paul Jenkins, Heike Wulff and Vladimir Yarov-Yarovoy
      Molecular Pharmacology April 2017, 91 (4) 392-402; DOI: https://doi.org/10.1124/mol.116.108068

  2. Niu, Qiankun

    1. AKT1, LKB1, and YAP1 Revealed as MYC Interactors with NanoLuc-Based Protein-Fragment Complementation Assay
      Xiulei Mo, Qi Qi, Andrei A. Ivanov, Qiankun Niu, Yin Luo, Jonathan Havel, Russell Goetze, Sydney Bell, Carlos S. Moreno, Lee A.D. Cooper, Margaret A. Johns, Fadlo R. Khuri, Yuhong Du and Haian Fu
      Molecular Pharmacology April 2017, 91 (4) 339-347; DOI: https://doi.org/10.1124/mol.116.107623

P

  1. Pessah, Isaac N.

    1. Divergent Mechanisms Leading to Signaling Dysfunction in Embryonic Muscle by Bisphenol A and Tetrabromobisphenol A
      Rui Zhang and Isaac N. Pessah
      Molecular Pharmacology April 2017, 91 (4) 428-436; DOI: https://doi.org/10.1124/mol.116.107342

  2. Petri, Björn

    1. Targeting a Proteinase-Activated Receptor 4 (PAR4) Carboxyl Terminal Motif to Regulate Platelet Function
      Rithwik Ramachandran, Koichiro Mihara, Pierre Thibeault, Christina M. Vanderboor, Björn Petri, Mahmoud Saifeddine, Michel Bouvier and Morley D. Hollenberg
      Molecular Pharmacology April 2017, 91 (4) 287-295; DOI: https://doi.org/10.1124/mol.116.106526

  3. Phan, Tiffany

    1. Sequence-Specific Regulation of Endocytic Lifetimes Modulates Arrestin-Mediated Signaling at the µ Opioid Receptor
      Zara Y. Weinberg, Amanda S. Zajac, Tiffany Phan, Daniel J. Shiwarski and Manojkumar A. Puthenveedu
      Molecular Pharmacology April 2017, 91 (4) 416-427; DOI: https://doi.org/10.1124/mol.116.106633

  4. Pohl, Oliver

    1. Open Access
      Differential Effects of Oxytocin Receptor Antagonists, Atosiban and Nolasiban, on Oxytocin Receptor–Mediated Signaling in Human Amnion and Myometrium
      Sung Hye Kim, Oliver Pohl, Andre Chollet, Jean-Pierre Gotteland, Adam D. J. Fairhurst, Phillip R. Bennett and Vasso Terzidou
      Molecular Pharmacology April 2017, 91 (4) 403-415; DOI: https://doi.org/10.1124/mol.116.106013

  5. Pressly, Brandon

    1. Structural Insights into the Atomistic Mechanisms of Action of Small Molecule Inhibitors Targeting the KCa3.1 Channel Pore
      Hai M. Nguyen, Vikrant Singh, Brandon Pressly, David Paul Jenkins, Heike Wulff and Vladimir Yarov-Yarovoy
      Molecular Pharmacology April 2017, 91 (4) 392-402; DOI: https://doi.org/10.1124/mol.116.108068

  6. Purvanov, Vladimir

    1. Modulation of Chemokine Receptor Function by Cholesterol: New Prospects for Pharmacological Intervention
      Daniel F. Legler, Christoph Matti, Julia M. Laufer, Barbara D. Jakobs, Vladimir Purvanov, Edith Uetz-von Allmen and Marcus Thelen
      Molecular Pharmacology April 2017, 91 (4) 331-338; DOI: https://doi.org/10.1124/mol.116.107151

  7. Puthenveedu, Manojkumar A.

    1. Sequence-Specific Regulation of Endocytic Lifetimes Modulates Arrestin-Mediated Signaling at the µ Opioid Receptor
      Zara Y. Weinberg, Amanda S. Zajac, Tiffany Phan, Daniel J. Shiwarski and Manojkumar A. Puthenveedu
      Molecular Pharmacology April 2017, 91 (4) 416-427; DOI: https://doi.org/10.1124/mol.116.106633

Q

  1. Qi, Qi

    1. AKT1, LKB1, and YAP1 Revealed as MYC Interactors with NanoLuc-Based Protein-Fragment Complementation Assay
      Xiulei Mo, Qi Qi, Andrei A. Ivanov, Qiankun Niu, Yin Luo, Jonathan Havel, Russell Goetze, Sydney Bell, Carlos S. Moreno, Lee A.D. Cooper, Margaret A. Johns, Fadlo R. Khuri, Yuhong Du and Haian Fu
      Molecular Pharmacology April 2017, 91 (4) 339-347; DOI: https://doi.org/10.1124/mol.116.107623

R

  1. Ramachandran, Rithwik

    1. Targeting a Proteinase-Activated Receptor 4 (PAR4) Carboxyl Terminal Motif to Regulate Platelet Function
      Rithwik Ramachandran, Koichiro Mihara, Pierre Thibeault, Christina M. Vanderboor, Björn Petri, Mahmoud Saifeddine, Michel Bouvier and Morley D. Hollenberg
      Molecular Pharmacology April 2017, 91 (4) 287-295; DOI: https://doi.org/10.1124/mol.116.106526

  2. Reyes-Cruz, Guadalupe

    1. Protein Kinase C Activation Promotes α1B-Adrenoceptor Internalization and Late Endosome Trafficking through Rab9 Interaction. Role in Heterologous Desensitization
      Marco A. Alfonzo-Méndez, David A. Hernández-Espinosa, Gabriel Carmona-Rosas, M. Teresa Romero-Ávila, Guadalupe Reyes-Cruz and J. Adolfo García-Sáinz
      Molecular Pharmacology April 2017, 91 (4) 296-306; DOI: https://doi.org/10.1124/mol.116.106583

  3. Romero-Ávila, M. Teresa

    1. Protein Kinase C Activation Promotes α1B-Adrenoceptor Internalization and Late Endosome Trafficking through Rab9 Interaction. Role in Heterologous Desensitization
      Marco A. Alfonzo-Méndez, David A. Hernández-Espinosa, Gabriel Carmona-Rosas, M. Teresa Romero-Ávila, Guadalupe Reyes-Cruz and J. Adolfo García-Sáinz
      Molecular Pharmacology April 2017, 91 (4) 296-306; DOI: https://doi.org/10.1124/mol.116.106583

S

  1. Saifeddine, Mahmoud

    1. Targeting a Proteinase-Activated Receptor 4 (PAR4) Carboxyl Terminal Motif to Regulate Platelet Function
      Rithwik Ramachandran, Koichiro Mihara, Pierre Thibeault, Christina M. Vanderboor, Björn Petri, Mahmoud Saifeddine, Michel Bouvier and Morley D. Hollenberg
      Molecular Pharmacology April 2017, 91 (4) 287-295; DOI: https://doi.org/10.1124/mol.116.106526

  2. Schrage, Ramona

    1. A New Molecular Mechanism To Engineer Protean Agonism at a G Protein–Coupled Receptor
      Anna De Min, Carlo Matera, Andreas Bock, Janine Holze, Jessica Kloeckner, Mathias Muth, Christian Traenkle, Marco De Amici, Terry Kenakin, Ulrike Holzgrabe, Clelia Dallanoce, Evi Kostenis, Klaus Mohr and Ramona Schrage
      Molecular Pharmacology April 2017, 91 (4) 348-356; DOI: https://doi.org/10.1124/mol.116.107276

  3. Shiwarski, Daniel J.

    1. Sequence-Specific Regulation of Endocytic Lifetimes Modulates Arrestin-Mediated Signaling at the µ Opioid Receptor
      Zara Y. Weinberg, Amanda S. Zajac, Tiffany Phan, Daniel J. Shiwarski and Manojkumar A. Puthenveedu
      Molecular Pharmacology April 2017, 91 (4) 416-427; DOI: https://doi.org/10.1124/mol.116.106633

  4. Si, Shuyi

    1. Identification of a Novel Liver X Receptor Agonist that Regulates the Expression of Key Cholesterol Homeostasis Genes with Distinct Pharmacological Characteristics
      Ni Li, Xiao Wang, Yanni Xu, Yuan Lin, Ningyu Zhu, Peng Liu, Duo Lu and Shuyi Si
      Molecular Pharmacology April 2017, 91 (4) 264-276; DOI: https://doi.org/10.1124/mol.116.105213

  5. Singh, Vikrant

    1. Structural Insights into the Atomistic Mechanisms of Action of Small Molecule Inhibitors Targeting the KCa3.1 Channel Pore
      Hai M. Nguyen, Vikrant Singh, Brandon Pressly, David Paul Jenkins, Heike Wulff and Vladimir Yarov-Yarovoy
      Molecular Pharmacology April 2017, 91 (4) 392-402; DOI: https://doi.org/10.1124/mol.116.108068

T

  1. Tankovic, Anel

    1. Functional Evaluation of a De Novo GRIN2A Mutation Identified in a Patient with Profound Global Developmental Delay and Refractory Epilepsy
      Wenjuan Chen, Anel Tankovic, Pieter B. Burger, Hirofumi Kusumoto, Stephen F. Traynelis and Hongjie Yuan
      Molecular Pharmacology April 2017, 91 (4) 317-330; DOI: https://doi.org/10.1124/mol.116.106781

  2. Terzidou, Vasso

    1. Open Access
      Differential Effects of Oxytocin Receptor Antagonists, Atosiban and Nolasiban, on Oxytocin Receptor–Mediated Signaling in Human Amnion and Myometrium
      Sung Hye Kim, Oliver Pohl, Andre Chollet, Jean-Pierre Gotteland, Adam D. J. Fairhurst, Phillip R. Bennett and Vasso Terzidou
      Molecular Pharmacology April 2017, 91 (4) 403-415; DOI: https://doi.org/10.1124/mol.116.106013

  3. Thelen, Marcus

    1. Modulation of Chemokine Receptor Function by Cholesterol: New Prospects for Pharmacological Intervention
      Daniel F. Legler, Christoph Matti, Julia M. Laufer, Barbara D. Jakobs, Vladimir Purvanov, Edith Uetz-von Allmen and Marcus Thelen
      Molecular Pharmacology April 2017, 91 (4) 331-338; DOI: https://doi.org/10.1124/mol.116.107151

  4. Thibeault, Pierre

    1. Targeting a Proteinase-Activated Receptor 4 (PAR4) Carboxyl Terminal Motif to Regulate Platelet Function
      Rithwik Ramachandran, Koichiro Mihara, Pierre Thibeault, Christina M. Vanderboor, Björn Petri, Mahmoud Saifeddine, Michel Bouvier and Morley D. Hollenberg
      Molecular Pharmacology April 2017, 91 (4) 287-295; DOI: https://doi.org/10.1124/mol.116.106526

  5. Traenkle, Christian

    1. A New Molecular Mechanism To Engineer Protean Agonism at a G Protein–Coupled Receptor
      Anna De Min, Carlo Matera, Andreas Bock, Janine Holze, Jessica Kloeckner, Mathias Muth, Christian Traenkle, Marco De Amici, Terry Kenakin, Ulrike Holzgrabe, Clelia Dallanoce, Evi Kostenis, Klaus Mohr and Ramona Schrage
      Molecular Pharmacology April 2017, 91 (4) 348-356; DOI: https://doi.org/10.1124/mol.116.107276

  6. Traynelis, Stephen F.

    1. Functional Evaluation of a De Novo GRIN2A Mutation Identified in a Patient with Profound Global Developmental Delay and Refractory Epilepsy
      Wenjuan Chen, Anel Tankovic, Pieter B. Burger, Hirofumi Kusumoto, Stephen F. Traynelis and Hongjie Yuan
      Molecular Pharmacology April 2017, 91 (4) 317-330; DOI: https://doi.org/10.1124/mol.116.106781

U

  1. Uetz-von Allmen, Edith

    1. Modulation of Chemokine Receptor Function by Cholesterol: New Prospects for Pharmacological Intervention
      Daniel F. Legler, Christoph Matti, Julia M. Laufer, Barbara D. Jakobs, Vladimir Purvanov, Edith Uetz-von Allmen and Marcus Thelen
      Molecular Pharmacology April 2017, 91 (4) 331-338; DOI: https://doi.org/10.1124/mol.116.107151

V

  1. Vanderboor, Christina M.

    1. Targeting a Proteinase-Activated Receptor 4 (PAR4) Carboxyl Terminal Motif to Regulate Platelet Function
      Rithwik Ramachandran, Koichiro Mihara, Pierre Thibeault, Christina M. Vanderboor, Björn Petri, Mahmoud Saifeddine, Michel Bouvier and Morley D. Hollenberg
      Molecular Pharmacology April 2017, 91 (4) 287-295; DOI: https://doi.org/10.1124/mol.116.106526

W

  1. Wagley, Yadav

    1. Epigenetic Activation of μ-Opioid Receptor Gene via Increased Expression and Function of Mitogen- and Stress-Activated Protein Kinase 1
      Yadav Wagley, Ping-Yee Law, Li-Na Wei and Horace H. Loh
      Molecular Pharmacology April 2017, 91 (4) 357-372; DOI: https://doi.org/10.1124/mol.116.106567

  2. Wang, Xiao

    1. Identification of a Novel Liver X Receptor Agonist that Regulates the Expression of Key Cholesterol Homeostasis Genes with Distinct Pharmacological Characteristics
      Ni Li, Xiao Wang, Yanni Xu, Yuan Lin, Ningyu Zhu, Peng Liu, Duo Lu and Shuyi Si
      Molecular Pharmacology April 2017, 91 (4) 264-276; DOI: https://doi.org/10.1124/mol.116.105213

  3. Wei, Li-Na

    1. Epigenetic Activation of μ-Opioid Receptor Gene via Increased Expression and Function of Mitogen- and Stress-Activated Protein Kinase 1
      Yadav Wagley, Ping-Yee Law, Li-Na Wei and Horace H. Loh
      Molecular Pharmacology April 2017, 91 (4) 357-372; DOI: https://doi.org/10.1124/mol.116.106567

  4. Weinberg, Zara Y.

    1. Sequence-Specific Regulation of Endocytic Lifetimes Modulates Arrestin-Mediated Signaling at the µ Opioid Receptor
      Zara Y. Weinberg, Amanda S. Zajac, Tiffany Phan, Daniel J. Shiwarski and Manojkumar A. Puthenveedu
      Molecular Pharmacology April 2017, 91 (4) 416-427; DOI: https://doi.org/10.1124/mol.116.106633

  5. Wulff, Heike

    1. Structural Insights into the Atomistic Mechanisms of Action of Small Molecule Inhibitors Targeting the KCa3.1 Channel Pore
      Hai M. Nguyen, Vikrant Singh, Brandon Pressly, David Paul Jenkins, Heike Wulff and Vladimir Yarov-Yarovoy
      Molecular Pharmacology April 2017, 91 (4) 392-402; DOI: https://doi.org/10.1124/mol.116.108068

X

  1. Xu, Yanni

    1. Identification of a Novel Liver X Receptor Agonist that Regulates the Expression of Key Cholesterol Homeostasis Genes with Distinct Pharmacological Characteristics
      Ni Li, Xiao Wang, Yanni Xu, Yuan Lin, Ningyu Zhu, Peng Liu, Duo Lu and Shuyi Si
      Molecular Pharmacology April 2017, 91 (4) 264-276; DOI: https://doi.org/10.1124/mol.116.105213

Y

  1. Yarov-Yarovoy, Vladimir

    1. Structural Insights into the Atomistic Mechanisms of Action of Small Molecule Inhibitors Targeting the KCa3.1 Channel Pore
      Hai M. Nguyen, Vikrant Singh, Brandon Pressly, David Paul Jenkins, Heike Wulff and Vladimir Yarov-Yarovoy
      Molecular Pharmacology April 2017, 91 (4) 392-402; DOI: https://doi.org/10.1124/mol.116.108068

  2. Yuan, Hongjie

    1. Functional Evaluation of a De Novo GRIN2A Mutation Identified in a Patient with Profound Global Developmental Delay and Refractory Epilepsy
      Wenjuan Chen, Anel Tankovic, Pieter B. Burger, Hirofumi Kusumoto, Stephen F. Traynelis and Hongjie Yuan
      Molecular Pharmacology April 2017, 91 (4) 317-330; DOI: https://doi.org/10.1124/mol.116.106781

Z

  1. Zajac, Amanda S.

    1. Sequence-Specific Regulation of Endocytic Lifetimes Modulates Arrestin-Mediated Signaling at the µ Opioid Receptor
      Zara Y. Weinberg, Amanda S. Zajac, Tiffany Phan, Daniel J. Shiwarski and Manojkumar A. Puthenveedu
      Molecular Pharmacology April 2017, 91 (4) 416-427; DOI: https://doi.org/10.1124/mol.116.106633

  2. Zhang, Rui

    1. Divergent Mechanisms Leading to Signaling Dysfunction in Embryonic Muscle by Bisphenol A and Tetrabromobisphenol A
      Rui Zhang and Isaac N. Pessah
      Molecular Pharmacology April 2017, 91 (4) 428-436; DOI: https://doi.org/10.1124/mol.116.107342

  3. Zhu, Ningyu

    1. Identification of a Novel Liver X Receptor Agonist that Regulates the Expression of Key Cholesterol Homeostasis Genes with Distinct Pharmacological Characteristics
      Ni Li, Xiao Wang, Yanni Xu, Yuan Lin, Ningyu Zhu, Peng Liu, Duo Lu and Shuyi Si
      Molecular Pharmacology April 2017, 91 (4) 264-276; DOI: https://doi.org/10.1124/mol.116.105213
Back to top

In this issue